US Stock MarketDetailed Quotes

ADVM Adverum Biotechnologies

Watchlist
  • 9.4300
  • +0.0400+0.43%
Trading Apr 26 13:21 ET
195.72MMarket Cap-812P/E (TTM)

About Adverum Biotechnologies Company

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.

Company Profile

SymbolADVM
Company NameAdverum Biotechnologies
Listing DateJul 31, 2014
Issue Price3.88
Founded2006
CEODr. Laurent Fischer, M.D.
MarketNASDAQ
Employees121
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address100 Cardinal Way
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063
Phone1-650-656-9323
Websitehttp://www.adverum.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Laurent Fischer, M.D.
  • Chief Executive Officer, President and Director
  • 2.91M
  • Linda Rubinstein
  • Chief Financial Officer and Principal Accounting Officer
  • 111.89K
  • Kishor Peter Soparkar
  • Chief Operating Officer
  • 1.35M
  • Setareh Seyedkazemi
  • Chief Development Officer
  • 1.52M
  • Patrick C. Machado, J.D.
  • Chairman of the Board
  • 141.51K
  • Soo Hong
  • Independent Director
  • 116.15K
  • Dr. Rabia Gurses Ozden, M.D.
  • Independent Director
  • 116.15K
  • Dr. C. David Nicholson, PhD
  • Independent Director
  • --
  • Dawn A. Svoronos
  • Independent Director
  • 89.72K
  • Dr. Scott M. Whitcup,M.D.
  • Independent Director
  • 89.72K
  • James Scopa
  • Independent Director
  • 94.72K
  • Dr. Mark Lupher, PhD
  • Independent Director
  • 82.22K
  • Dr. Reed V. Tuckson, M.D.
  • Independent Director
  • 82.22K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg